Everence Capital Management Inc. trimmed its holdings in shares of Align Technology, Inc. (NASDAQ:ALGN – Get Rating) by 12.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,490 shares of the medical equipment provider’s stock after selling 221 shares during the period. Everence Capital Management Inc.’s holdings in Align Technology were worth $314,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in ALGN. Raymond James Trust N.A. raised its stake in shares of Align Technology by 39.4% during the 1st quarter. Raymond James Trust N.A. now owns 934 shares of the medical equipment provider’s stock worth $407,000 after purchasing an additional 264 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Align Technology by 11.1% during the 1st quarter. Dimensional Fund Advisors LP now owns 180,978 shares of the medical equipment provider’s stock worth $78,911,000 after purchasing an additional 18,153 shares during the period. Prudential PLC bought a new stake in shares of Align Technology during the 1st quarter worth $955,000. Cetera Investment Advisers raised its stake in shares of Align Technology by 4.9% during the 1st quarter. Cetera Investment Advisers now owns 1,713 shares of the medical equipment provider’s stock worth $747,000 after purchasing an additional 80 shares during the period. Finally, Sequoia Financial Advisors LLC raised its stake in shares of Align Technology by 17.1% during the 1st quarter. Sequoia Financial Advisors LLC now owns 526 shares of the medical equipment provider’s stock worth $229,000 after purchasing an additional 77 shares during the period. 84.90% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research firms have recently commented on ALGN. Stifel Nicolaus lifted their target price on Align Technology from $265.00 to $375.00 and gave the stock a “buy” rating in a research note on Thursday, February 2nd. StockNews.com initiated coverage on Align Technology in a report on Thursday, March 16th. They issued a “hold” rating for the company. CICC Research initiated coverage on Align Technology in a report on Thursday, March 23rd. They issued a “market perform” rating for the company. Evercore ISI lifted their price objective on Align Technology from $230.00 to $375.00 and gave the stock an “outperform” rating in a report on Thursday, February 2nd. Finally, OTR Global raised Align Technology from a “mixed” rating to a “positive” rating in a report on Friday, March 31st. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Align Technology presently has a consensus rating of “Moderate Buy” and a consensus price target of $358.78.
Insider Activity
Align Technology Trading Up 0.3 %
Shares of ALGN opened at $342.27 on Friday. The company has a market cap of $26.27 billion, a PE ratio of 74.25, a price-to-earnings-growth ratio of 3.24 and a beta of 1.60. The stock has a 50-day moving average price of $321.66 and a 200-day moving average price of $251.77. Align Technology, Inc. has a 12-month low of $172.05 and a 12-month high of $431.27.
Align Technology (NASDAQ:ALGN – Get Rating) last issued its quarterly earnings results on Wednesday, February 1st. The medical equipment provider reported $1.28 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.23 by $0.05. The firm had revenue of $901.52 million during the quarter, compared to the consensus estimate of $889.27 million. Align Technology had a return on equity of 11.90% and a net margin of 9.68%. As a group, analysts predict that Align Technology, Inc. will post 6.43 earnings per share for the current year.
Align Technology Profile
Align Technology, Inc engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion.
See Also
- Get a free copy of the StockNews.com research report on Align Technology (ALGN)
- MarketBeat Week in Review – 4/10 – 4/14
- What is an IRA Account? All About IRAs
- Investing in Quantum Computing: A Guide
- Earnings Beat Proves Citigroup to be The Cheaper Bank Stock
- How to Invest in an IRA in 7 Simple Steps
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.